Quercetin up-regulates LDL receptor expression in HepG2 cells

Phytotherapy Research

Volumn 26, Issue 11, 2012, Pages 1688-1694

  Moon, Jiyoung ^a   Lee, Seung Min ^a   Do, Hyun Ju ^a   Cho, Yoonsu ^a   Chung, Ji Hyung ^b   Shin, Min Jeong ^a  

^a Korea University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

ERK; JNK; LDLR; quercetin; SREBP2

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLOHEXIMIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PUROMYCIN; QUERCETIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ASSAY; CELL STRAIN HEPG2; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LDLR GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEP G2 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; QUERCETIN; RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84867863236     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4646     Document Type: Article

References (39)

1. Alia M, Mateos R, Ramos S, et al,. 2006. Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). Eur J Nutr 45: 19-28.
2. Bieger J, Cermak R, Blank R, et al,. 2008. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138: 1417-1420.
3. Boots AW, Haenen GR, Bast A,. 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585: 325-337.
4. Briggs MR, Yokoyama C, Wang X, et al,. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 268: 14490-14496.
5. Brown MS, Goldstein JL,. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.
6. Chen JW, Zhu ZQ, Hu TX, et al,. 2002. Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Pharmacol Sin 23: 667-672.
7. Croons V, Martinet W, Herman AG, et al,. 2008. Differential effect of the protein synthesis inhibitors puromycin and cycloheximide on vascular smooth muscle cell viability. J Phamacol Exp Ther 325: 824-832.
8. DeBose-Boyd RA,. 2008. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 18: 609-621.
9. Egert S, Boesch-Saadatmandi C, Wolffram S, et al,. 2010. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140: 278-284.
10. Formica JV, Regelson W,. 1995. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 33: 1061-1080.
11. Goldstein JL, Brown MS,. 1987. Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 76: 504-507.
12. Hertog MG, Hollman PC,. 1996. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 50: 63-71.
13. Horton JD, Goldstein JL, Brown MS,. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
14. Igarashi K, Ohmuma M,. 1995. Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem 59: 595-601.
15. Janisch KM, Williamson G, Needs P, et al,. 2004. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res 38: 877-884.
16. Kamada C, da Silva EL, Ohnishi-Kameyama M, et al,. 2005. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res 39: 185-194.
17. Kobuchi H, Roy S, Sen CK, et al,. 1999. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol 277: C403-C411.
18. Lee KH, Park E, Lee HJ, et al,. 2011. Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr Res Pract 5: 28-33.
19. Lee S, Lim HJ, Park JH, et al,. 2007. Berberine-induced LDLR up-regulation involves JNK pathway. Biochem Biophys Res Commun 362: 853-857.
20. Li C, Kraemer FB, Ahlborn TE, et al,. 1999. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter. J Biol Chem 274: 6747-6753.
21. Luepker RV,. 2011. Cardiovascular disease: rise, fall, and future prospects. Ann Rev Pub Health 32: 1-3.
22. McKenney JM,. 2001. Pharmacotherapy of dyslipidemia. Cardio Drugs Ther 15: 413-422.
23. Mink PJ, Scrafford CG, Barraj LM, et al,. 2007. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85: 895-909.
24. Moon SK, Cho GO, Jung SY, et al,. 2003. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 301: 1069-1078.
25. Nawrocki JW, Weiss SR, Davidson MH, et al,. 1995. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 15: 678-682.
26. Nickel T, Hanssen H, Sisic Z, et al,. 2011. Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr 50: 163-172.
27. Odbayar TO, Badamhand D, Kimura T, et al,. 2006. Comparative studies of some phenolic compounds (quercetin, rutin, and ferulic acid) affecting hepatic fatty acid synthesis in mice. J Agric Food Chem 54: 8261-8265.
28. Pak YK, Kanuck MP, Berrios D, et al,. 1996. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. J Lipid Res 37: 985-998.
29. Prince PS, Sathya B,. 2010. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur J Pharmacol 635: 142-148.
30. Rader DJ,. 2001. A new feature on the cholesterol-lowering landscape. Nat Med 7: 1282-1284.
31. Sestili P, Guidarelli A, Dacha M, et al,. 1998. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic Biol Med 25: 196-200.
32. Soleas GJ, Grass L, Josephy PD, et al,. 2002. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 35: 119-124.
33. Steinberg D, Parthasarathy S, Carew TE, et al,. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924.
34. Stopeck AT, Nicholson AC, Mancini FP, et al,. 1993. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 268: 17489-17494.
35. Wang X, Briggs MR, Hua X, et al,. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 268: 14497-14504.
36. Williams RJ, Spencer JP, Rice-Evans C,. 2004. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849.
37. Yoshizumi M, Tsuchiya K, Kirima K, et al,. 2001. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60: 656-665.
38. Zhao L, Wu J, Wang Y, et al,. 2011a. Cholesterol metabolism is modulated by quercetin in rats. J Agric Food Chem 59: 1104-1108.
39. Zhao L, Wu J, Yang J, et al,. 2011b. Dietary quercetin supplementation increases serum antioxidant capacity and alters hepatic gene expression profile in rats. Exp Biol Med (Maywood) 236: 701-706.